Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2012; 8(10):1420-1430. doi:10.7150/ijbs.5273 This issue Cite

Review

Immunotherapies: The Blockade of Inhibitory Signals

Yan-Ling Wu1✉, Jing Liang2, Wen Zhang2✉, Yoshimasa Tanaka3, Hiroshi Sugiyama4

1. Virus Inspection Department of Zhejiang Provincial Center for Disease Control and Prevention, 630 Xincheng Road, Hangzhou, 310051, China.
2. Department of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, 310014, China.
3. Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
4. Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.

✉ Corresponding author: Yan-Ling Wu, Virus Inspection Department of Zhejiang Provincial Center for Disease Control and Prevention, 630 Xincheng Road, Hangzhou, 310051, PR China; Tel: +86-571-87115282; Fax: +86-571-87115282; e-mail: ylwuzj.cn; Wen More

Citation:
Wu YL, Liang J, Zhang W, Tanaka Y, Sugiyama H. Immunotherapies: The Blockade of Inhibitory Signals. Int J Biol Sci 2012; 8(10):1420-1430. doi:10.7150/ijbs.5273. https://www.ijbs.com/v08p1420.htm
Other styles

File import instruction

Abstract

T lymphocytes require signaling by the T cell receptor and by nonclonotypic cosignaling receptors. The costimulatory and inhibitory signals profoundly influence the course of immune responses by amplifying or reducing the transcriptional effects of T cell receptor triggering. The inhibitory receptors such as CTLA-4, PD-1, and BTLA have recently drawn much attention as potential targets for immunotherapies. This review focuses on the progress that has been made with the mentioned receptors in the field of immunotherapies for autoimmune diseases, malignancies, infectious diseases, and transplantation.

Keywords: Inhibitory receptors, CTLA-4, PD-1, BTLA, immunotherapy.

Citation styles

APA
Wu, Y.L., Liang, J., Zhang, W., Tanaka, Y., Sugiyama, H. (2012). Immunotherapies: The Blockade of Inhibitory Signals. International Journal of Biological Sciences, 8(10), 1420-1430. https://doi.org/10.7150/ijbs.5273.

ACS
Wu, Y.L.; Liang, J.; Zhang, W.; Tanaka, Y.; Sugiyama, H. Immunotherapies: The Blockade of Inhibitory Signals. Int. J. Biol. Sci. 2012, 8 (10), 1420-1430. DOI: 10.7150/ijbs.5273.

NLM
Wu YL, Liang J, Zhang W, Tanaka Y, Sugiyama H. Immunotherapies: The Blockade of Inhibitory Signals. Int J Biol Sci 2012; 8(10):1420-1430. doi:10.7150/ijbs.5273. https://www.ijbs.com/v08p1420.htm

CSE
Wu YL, Liang J, Zhang W, Tanaka Y, Sugiyama H. 2012. Immunotherapies: The Blockade of Inhibitory Signals. Int J Biol Sci. 8(10):1420-1430.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use